• Humacyte Inc. shares are down 6.0% today, continuing a multi-day slide that began in early June.
  • The decline is influenced by the $50 million public offering of common stock, priced at $1.05 per share, announced on June 11, 2026, which led to a 19.40% stock drop that day.
  • This significant capital raise and subsequent dilution are key factors contributing to the recent price volatility and profit-taking.